Singular Genomics Systems Investor Relations Material
Latest events
Q2 2024
Singular Genomics Systems
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Singular Genomics Systems Inc
Access all reports
Singular Genomics Systems Inc. is a life sciences technology company focused on developing next-generation sequencing (NGS) platforms and genomic analysis solutions. The company’s flagship products include the G4 Sequencing Platform, designed to deliver fast, accurate, and flexible sequencing for research and clinical applications. Singular Genomics aims to support areas such as oncology, immunology, and inherited disease research. Singular Genomics is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
OMIC
Country
🇺🇸 United States